Suppr超能文献

糖尿病与心力衰竭风险。

Diabetes and the risk of heart failure.

机构信息

Section of Cardiology, Heart and Vascular Center, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA.

出版信息

Heart Fail Clin. 2012 Jan;8(1):125-33. doi: 10.1016/j.hfc.2011.08.008. Epub 2011 Oct 13.

Abstract

Prevalence of diabetes and heart failure are increasing exponentially worldwide. Diabetes is well-known to increase the risk of heart failure independent of other traditional risk factors and ischemia. Current evidence indicates the presence of several biochemical and molecular changes associated with diabetes that lead to diastolic dysfunction or American Heart Association stage B heart failure. Some, if not all, changes may also predate the development of frank diabetes. In this review, the authors present some of the epidemiologic evidence and a brief description of major mechanistic pathways that favor the development of heart failure in prediabetic and diabetic states.

摘要

全球范围内,糖尿病和心力衰竭的患病率呈指数级增长。众所周知,糖尿病会增加心力衰竭的风险,独立于其他传统危险因素和缺血。目前的证据表明,存在与糖尿病相关的几种生化和分子变化,导致舒张功能障碍或美国心脏协会 B 期心力衰竭。如果不是全部,那么其中一些变化可能也早于糖尿病的发生。在这篇综述中,作者提出了一些流行病学证据,并简要描述了有利于糖尿病前期和糖尿病状态下心力衰竭发展的主要机制途径。

相似文献

1
Diabetes and the risk of heart failure.
Heart Fail Clin. 2012 Jan;8(1):125-33. doi: 10.1016/j.hfc.2011.08.008. Epub 2011 Oct 13.
2
Heart failure in diabetes and related conditions.
J Card Fail. 2007 Dec;13(10):861-73. doi: 10.1016/j.cardfail.2007.07.007.
3
Epidemiology of the diabetic heart.
Coron Artery Dis. 2005 Nov;16 Suppl 1:S3-S10. doi: 10.1097/00019501-200511001-00002.
4
[Risk factors for heart failure in women: diabetes].
G Ital Cardiol (Rome). 2012 May;13(5 Suppl 1):12S-17S.
7
Heart failure and diabetes.
Rom J Intern Med. 2004;42(2):267-75.
8
[Epidemiology of heart failure].
Rev Prat. 2010 Sep 20;60(7):911-5.
9
Heart failure and nephropathy: catastrophic and interrelated complications of diabetes.
Clin J Am Soc Nephrol. 2006 Mar;1(2):193-208. doi: 10.2215/CJN.00540705. Epub 2005 Dec 7.
10
Heart failure: epidemiologic update.
Crit Care Nurs Q. 2009 Jan-Mar;32(1):24-32. doi: 10.1097/01.CNQ.0000343131.27318.36.

引用本文的文献

3
Molecular Pathways in Diabetic Cardiomyopathy and the Role of Anti-hyperglycemic Drugs Beyond Their Glucose Lowering Effect.
J Lipid Atheroscler. 2025 Jan;14(1):54-76. doi: 10.12997/jla.2025.14.1.54. Epub 2024 Nov 28.
4
Therapeutic Interventions for Diabetes Mellitus-associated Complications.
Curr Diabetes Rev. 2025;21(8):e030524229631. doi: 10.2174/0115733998291870240408043837.
5
MicroRNAs Targeting Critical Molecular Pathways in Diabetic Cardiomyopathy Emerging Valuable for Therapy.
Cardiovasc Hematol Agents Med Chem. 2024;22(3):298-307. doi: 10.2174/0118715257265947231129074526.
6
The double-hit protocol induces HFpEF and impairs myocardial ubiquitin-proteasome system performance in FVB/N mice.
Front Physiol. 2023 Jun 8;14:1208153. doi: 10.3389/fphys.2023.1208153. eCollection 2023.
8
Role of histone deacetylase inhibitors in diabetic cardiomyopathy in experimental models (Review).
Med Int (Lond). 2022 Aug 2;2(4):26. doi: 10.3892/mi.2022.51. eCollection 2022 Jul-Aug.
9
Causes of hospitalization in the USA between 2005 and 2018.
Eur Heart J Open. 2021 Jun 15;1(1):oeab001. doi: 10.1093/ehjopen/oeab001. eCollection 2021 Aug.
10
SIRT3 attenuates coronary atherosclerosis in diabetic patients by regulating endothelial cell function.
J Clin Lab Anal. 2022 Aug;36(8):e24586. doi: 10.1002/jcla.24586. Epub 2022 Jul 6.

本文引用的文献

1
The adverse impact of diabetes mellitus on left ventricular remodeling and function in patients with severe aortic stenosis.
Circ Heart Fail. 2011 May;4(3):286-92. doi: 10.1161/CIRCHEARTFAILURE.110.960039. Epub 2011 Feb 25.
3
Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes.
JACC Cardiovasc Imaging. 2010 Dec;3(12):1207-15. doi: 10.1016/j.jcmg.2010.09.014.
4
Heart disease and stroke statistics--2011 update: a report from the American Heart Association.
Circulation. 2011 Feb 1;123(4):e18-e209. doi: 10.1161/CIR.0b013e3182009701. Epub 2010 Dec 15.
5
Enhancing the metabolic substrate: PPAR-alpha agonists in heart failure.
Heart Fail Rev. 2012 Jan;17(1):35-43. doi: 10.1007/s10741-010-9208-0.
10
Effects of intensive blood-pressure control in type 2 diabetes mellitus.
N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验